Picardi M, Giordano C. Comment on “Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study.”. Haematologica 2021;106(4):1226-1227; https://doi.org/10.3324/haematol.2020.278203.